For example, flow cytometry can distinguish different cellular properties from morphology to cell cycle stage. Furthermore, the information provided by a flow cytometer reflects the individual cells ...

In the relentless fight against cancer, a new technology promises to shed light on how we track and understand the spread of this disease within the body. A research team from Northeastern University ...

The UAB Flow Cytometry Lab is home to a staff of medical laboratory professionals who perform complex testing using state-of-the-art flow cytometry equipment. This testing, through research, education ...

Housed inside BD Biosciences’ latest cell sorter, the BD FACSymphony™ S6 Cell Sorter*, is an array of sophisticated optical technologies. There is space for up to 9 different lasers, along with ...

In this webinar, Jorge López, MSc, Flow Cytometry and Hematology Specialist, will discuss the implementation of PIDOT within a Next Generation Flow™ cytometry framework as a sta ...

Flow cytometry remains a critical technology for the high-throughput analysis of single cells in complex populations. Attention to good analysis practices is more important than ever due to the recent ...

MRD refers to cancer cells remaining post-treatment, undetectable by standard imaging, indicating potential recurrence risk. MRD testing methods include flow cytometry and genetic tests, offering ...

Advancements in immuno-oncology have been moving at an ever-quickening pace. From the development of new CAR-T therapies to a better understanding of the mechanism of action of monoclonal antibody ...

Cytometry and immune profiling have emerged as indispensable techniques in modern biomedical research. These methodologies enable the precise analysis of individual cells within heterogeneous ...

Recently, we have developed and optimized a protocol for the large-scale isolation of RMPs and PMPs from transfusion units. Nearly all erythrocyte unit-derived MPs isolated with this protocol are ...

Not all patients respond well to chimeric antigen receptor (CAR) T cell therapies, which reprogram a patient’s own immune cells to recognize and attack cancer. A way to optimize these treatments is to ...